Related Experiment Video
Updated: Jun 17, 2026
Preparation and Culture of Myogenic Precursor Cells/Primary Myoblasts from Skeletal Muscle of Adult and Aged Humans
Published on: February 16, 2017
[Care continuity for patients with myasthenia gravis during transition from childhood to adulthood]
1Segawa Neurological Clinic for Children.
Insights
Myasthenia gravis in Japan presents with childhood onset and specific HLA links. Early, tailored treatments like anticholinesterase, steroids, or thymectomy lead to remission in most cases.
Area of Science:
- Neurology
- Immunology
- Genetics
Context:
- Myasthenia gravis (MG) onset in Japan exhibits bimodal peaks, notably in childhood.
- Specific HLA associations are observed in pediatric MG cases.
- Clinical presentations include ocular, latent generalized, and generalized types, with latent generalized being most common.
Purpose:
- To analyze clinical characteristics, treatment responses, and outcomes of myasthenia gravis in Japan.
- To investigate the relationship between clinical types, age at onset, and treatment efficacy.
- To understand the role of anti-acetylcholine receptor antibodies and age-dependent titer changes.
Summary:
- MG onset in Japan shows peaks in childhood and adulthood, with specific HLA associations in pediatric patients.
- Clinical types (ocular, latent generalized, generalized) and age influence disease characteristics and treatment effectiveness.
- Anti-acetylcholine receptor antibody titers are generally low but increase with age and in generalized MG.
- Treatment options include anticholinesterase inhibitors, steroids, and thymectomy, with early, adequate treatment achieving remission in most patients.
Impact:
- This study highlights the importance of early diagnosis and individualized treatment strategies for myasthenia gravis in Japan.
- Understanding age- and type-specific characteristics can optimize therapeutic interventions and improve patient outcomes.
- Monitoring for complications and side effects of long-term treatments is crucial for comprehensive patient care.
Abstract:
The onset of myasthenia gravis in Japan shows two peaks, the highest in childhood, which has specific HLA association. The clinical types are ocular, latent general and general types, latent general is most frequently observed. Clinical characteristics and effects of the treatments are associated with the clinical types and ages at onset. Anti-acetylcholine receptor antibody is negative to low positive. Age-dependent changes, i. e., higher as age advances are observed, and general type shows higher titer than other types. Treatments consist of anticholinesterase, steroid and thymectomy. Most ocular and latent general type responded to anticholinesterase and/or steroid. General type with onset in teens often needed thymectomy. The early initiation of the adequate treatments resulted in the complete remission in most cases. Associated complications and side effects of long-term treatments should be carefully observed.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:22Myasthenia Gravis ll: Pathophysiology
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:28Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:22Myocarditis IV: Nursing Management
01:30Asthma-IV: Nursing Management
First, in...